32265625|t|TGF-beta1 Provides Neuroprotection via Inhibition of Microglial Activation in 3-Acetylpyridine-Induced Cerebellar Ataxia Model Rats.
32265625|a|Cerebellar ataxias (CAs) consist of a heterogeneous group of neurodegenerative diseases hallmarked by motor deficits and deterioration of the cerebellum and its associated circuitries. Neuroinflammatory responses are present in CA brain, but how neuroinflammation may contribute to CA pathogenesis remain unresolved. Here, we investigate whether transforming growth factor (TGF)-beta1, which possesses anti-inflammatory and neuroprotective properties, can ameliorate the microglia-mediated neuroinflammation and thereby alleviate neurodegeneration in CA. In the current study, we administered TGF-beta1 via the intracerebroventricle (ICV) in CA model rats, by intraperitoneal injection of 3-acetylpyridine (3-AP), to reveal the neuroprotective role of TGF-beta1. The TGF-beta1 administration after 3-AP injection ameliorated motor impairments and reduced the calbindin-positive neuron loss and apoptosis in the brain stem and cerebellum. Meanwhile, 3-AP induced microglial activation and inflammatory responses in vivo, which were determined by morphological alteration and an increase in expression of CD11b, enhancement of percentage of CD40 + and CD86 + microglial cells, upregulation of pro-inflammatory mediators, tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta, and a downregulation of neurotrophic factor, insulin-like growth factor (IGF)-1 in the brain stem and cerebellum. TGF-beta1 treatment significantly prevented all the changes caused by 3-AP. In addition, in vitro experiments, TGF-beta1 directly attenuated 3-AP-induced microglial activation and inflammatory responses in primary cultures. Purkinje cell exposure to supernatants of primary microglia that had been treated with TGF-beta1 reduced neuronal loss and apoptosis induced by 3-AP-treated microglial supernatants. Furthermore, the protective effect was similar to those treated with TNF-alpha-neutralizing antibody. These findings suggest that TGF-beta1 protects against neurodegeneration in 3-AP-induced CA rats via inhibiting microglial activation and at least partly TNF-alpha release.
32265625	0	9	TGF-beta1	Gene	59086
32265625	78	94	3-Acetylpyridine	Chemical	MESH:C010835
32265625	103	120	Cerebellar Ataxia	Disease	MESH:D002524
32265625	127	131	Rats	Species	10116
32265625	133	151	Cerebellar ataxias	Disease	MESH:D002524
32265625	153	156	CAs	Disease	MESH:D002524
32265625	194	220	neurodegenerative diseases	Disease	MESH:D019636
32265625	235	249	motor deficits	Disease	MESH:D009461
32265625	318	335	Neuroinflammatory	Disease	MESH:D000090862
32265625	361	363	CA	Disease	
32265625	379	396	neuroinflammation	Disease	MESH:D000090862
32265625	415	417	CA	Disease	
32265625	479	517	transforming growth factor (TGF)-beta1	Gene	59086
32265625	540	552	inflammatory	Disease	MESH:D007249
32265625	623	640	neuroinflammation	Disease	MESH:D000090862
32265625	663	680	neurodegeneration	Disease	MESH:D019636
32265625	684	686	CA	Disease	
32265625	726	735	TGF-beta1	Gene	59086
32265625	775	777	CA	Disease	
32265625	784	788	rats	Species	10116
32265625	822	838	3-acetylpyridine	Chemical	MESH:C010835
32265625	840	844	3-AP	Chemical	MESH:C010835
32265625	885	894	TGF-beta1	Gene	59086
32265625	900	909	TGF-beta1	Gene	59086
32265625	931	935	3-AP	Chemical	MESH:C010835
32265625	992	1001	calbindin	Gene	83839
32265625	1082	1086	3-AP	Chemical	MESH:C010835
32265625	1121	1133	inflammatory	Disease	MESH:D007249
32265625	1236	1241	CD11b	Gene	25021
32265625	1272	1276	CD40	Gene	171369
32265625	1283	1287	CD86	Gene	56822
32265625	1328	1340	inflammatory	Disease	MESH:D007249
32265625	1352	1385	tumor necrosis factor (TNF)-alpha	Gene	24835
32265625	1390	1412	interleukin (IL)-1beta	Gene	24494
32265625	1459	1493	insulin-like growth factor (IGF)-1	Gene	24482
32265625	1528	1537	TGF-beta1	Gene	59086
32265625	1598	1602	3-AP	Chemical	MESH:C010835
32265625	1639	1648	TGF-beta1	Gene	59086
32265625	1669	1673	3-AP	Chemical	MESH:C010835
32265625	1708	1720	inflammatory	Disease	MESH:D007249
32265625	1839	1848	TGF-beta1	Gene	59086
32265625	1857	1870	neuronal loss	Disease	MESH:D009410
32265625	1896	1900	3-AP	Chemical	MESH:C010835
32265625	2003	2012	TNF-alpha	Gene	24835
32265625	2064	2073	TGF-beta1	Gene	59086
32265625	2091	2108	neurodegeneration	Disease	MESH:D019636
32265625	2112	2116	3-AP	Chemical	MESH:C010835
32265625	2125	2127	CA	Disease	
32265625	2128	2132	rats	Species	10116
32265625	2190	2199	TNF-alpha	Gene	24835
32265625	Positive_Correlation	MESH:C010835	171369
32265625	Positive_Correlation	MESH:C010835	MESH:D007249
32265625	Positive_Correlation	MESH:C010835	24494
32265625	Association	MESH:D019636	24835
32265625	Association	MESH:C010835	24835
32265625	Positive_Correlation	MESH:C010835	56822
32265625	Negative_Correlation	MESH:D009410	59086
32265625	Positive_Correlation	MESH:C010835	MESH:D002524
32265625	Negative_Correlation	59086	83839
32265625	Association	MESH:C010835	59086
32265625	Negative_Correlation	MESH:D007249	59086
32265625	Association	MESH:C010835	24482
32265625	Association	MESH:D007249	24494
32265625	Positive_Correlation	MESH:C010835	25021

